|
Il Dipartimento di Scienze della Vita di Unimore promuove il workshop "MORE Pharma - Biotech" . L'evento, giunto alla sua terza edizione ed intitolato ' Tra Scuola, Università e mondo del lavoro: quali prospettive? ' , si terrà venerdì 20 febbraio, dalle ore 9:00 alle ...
Reggio 2000
-
2 ore fa
|
|
|
|
...digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more ... Laife Reply Laife Reply is a Reply Group company operating in the Health, Welfare and Pharma sectors. ...
01Net
-
10-2-2026
|
|
|
|
... more efficient, and truly patient - centric. Pharma, biotech and CROs interested in working with us can reach out here . About Evinova Evinova empowers life science leaders to accelerate better ...
01Net
-
9-2-2026
|
|
|
|
... arthritis, and more By unifying pricing, pharmacy enablement, and a trusted consumer experience, GoodRx enables pharma manufacturers to rapidly deploy and scale emerging pricing models with minimal ...
01Net
-
6-2-2026
|
|
|
|
... pharma, and travel, with existing customers expanding their relationships and running more campaigns as results improved. Building the Industry s Best Team Cognitiv s momentum reflects not only ...
01Net
-
4-2-2026
|
|
|
|
Il programma prosegue venerdì 20 febbraio 2026 con il Workshop MORE Pharma - Biotech tra Scuola, Università e mondo del lavoro: quali prospettive? (Aula U1.3, MO51 in via Campi, 103), pensato come ...
Reggio 2000
-
1-2-2026
|
|
|
|
... will enable hospitals and clinicians to access a more unified ecosystem for newborn care. Keriton ... Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ...
01Net
-
28-1-2026
|
|
|
|
Learn more at argano.com . About Pharosity Consulting Pharosity Consulting is a life sciences consulting firm focused on Gross - to - Net, government pricing, commercial contracting, emerging pharma ...
01Net
-
27-1-2026
|
|
|
|
BIOMAKERS has built an end - to - end system that creates durable value for pharma partners while enabling faster, more effective research and development. This financing marks a transition from ...
01Net
-
20-1-2026
|
|
|
|
By industry, several sectors recorded gains of more than 50 percent, including energy (up 89 percent) and healthcare/pharma (up 85 percent). However, that was offset by declines in other large ...
01Net
-
20-1-2026
|
|
|
